Monday, August 19, 2019

Interregional differences in somatic genetic landscape diversify prognosis in glioblastoma

Researchers have conducted the largest-ever retrospective cohort study for Japanese patients with glioblastoma (GBM), proposing an underlying prognosis biomarker responsible for the survival difference between two cohorts: an original Japanese cohort and a dataset from The Cancer Genome Atlas (TCGA).

from Latest Science News -- ScienceDaily https://ift.tt/2MmUYyp
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ozempic may have revealed the brain’s hidden “craving center”

Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists ar...